SATISFACTORY CLINICAL EVOLUTION OF FIVE CORONAVIRUS PATIENTS TREATED PREVIOUSLY WITH RUXOLITINIB BY NMPC. IS RUXOLITINIB TREATMENT A PROTECTIVE FACTOR? | Haematologica; 105:355-356, 2020. | Web of Science

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

SATISFACTORY CLINICAL EVOLUTION OF FIVE CORONAVIRUS PATIENTS TREATED PREVIOUSLY WITH RUXOLITINIB BY NMPC. IS RUXOLITINIB TREATMENT A PROTECTIVE FACTOR?

Velasco, V. A.; Serrano, L. J.; Prieto, P. E.; Mata, S. R.; Lopez, L. J. L.; Martos, M. R.; Salvatierra, C. G.; Sola, A. E.; Rosado, S. B.; Urbina, P. R.; Miranda, C. C.; Llamas, S. P..

Haematologica ; 105:355-356, 2020.

Article in Spanish | Web of Science | ID: covidwho-1271134

Search on Google

Collection: Databases of international organizations Database: Web of Science Type of study: Etiology study / Prognostic study Language: Spanish Journal: Haematologica Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Collection: Databases of international organizations Database: Web of Science Type of study: Etiology study / Prognostic study Language: Spanish Journal: Haematologica Year: 2020 Document Type: Article